KMDA
Kamada Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic
Señales de momentum (gestores comparables):
amplitud de titulares -12.0% ·
flujo de acciones -4.1% ·
nuevas posiciones netas -13.6%
· fórmula
Distribución amplia: acciones en descenso y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2026
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 27 | +5 | 2.57M | $19.13M | +6 | −1 |
| Q1 2026 | 22 | -3 | 2.50M | $509.41M | +1 | −4 |
| Q4 2025 | 25 | -1 | 2.61M | $442.17M | n/a | −1 |
| Q3 2025 | 12 | 0 | 1.99M | $13.83M | n/a | n/a |
| Q2 2025 | 9 | +2 | 1.71M | $13.25M | +2 | n/a |
| Q1 2025 | 6 | +2 | 1.56M | $10.32M | +2 | n/a |
| Q4 2024 | 4 | 0 | 1.20M | $7.32M | n/a | n/a |
| Q3 2024 | 4 | 0 | 1.28M | $6.90M | n/a | n/a |
| Q2 2024 | 4 | n/a | 993.01K | $4.93M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wells Fargo & Company/Mn | 597.24K | -1.1% | $493.54M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 762.95K | -9.1% | $6.36M | 0.0% | ▼ Trim | 8 | SEC ↗ |
| 3 | ARK Investment Management ✦ | 269.56K | Nuevo | $2.23M | 0.0% | New | 1 | SEC ↗ |
| 4 | Two Sigma Investments ✦ | 194.25K | +38.1% | $1.62M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 5 | Envestnet Asset Management Inc | 166.14K | +1539.7% | $1.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Marshall Wace ✦ | 149.99K | -23.8% | $1.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Goldman Sachs Group ✦ | 72.95K | -56.5% | $608,445 | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 8 | Man Group plc | 54.76K | +59.7% | $456,682 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Millennium Management ✦ | 46.93K | -70.2% | $391,430 | 0.0% | ▼ Trim | 8 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 44.53K | +15.8% | $371,355 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Geode Capital Management ✦ (pasivo) | 37.50K | +27.5% | $312,775 | 0.0% | ▲ Add | 8 | SEC ↗ |
| 12 | Jane Street Group, Llc | 29.38K | +38.9% | $245,029 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | JPMorgan Chase ✦ | 25.19K | -56.0% | $203,299 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Bank Of America Corp /De/ | 21.10K | -46.8% | $176,007 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Focus Partners Wealth | 10.00K | 0.0% | $83,400 | 0.0% | Held | 2 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 9.96K | -19.8% | $83,050 | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 17 | Barclays Plc | 5.26K | +9.9% | $43,868 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | UBS Group AG | 2.94K | -94.7% | $24,545 | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 19 | Citigroup Inc | 1.61K | +0.2% | $13,295 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Bnp Paribas Financial Markets | 1.20K | -3.3% | $10,033 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Royal Bank Of Canada | 242 | -80.9% | $2,000 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Osaic Holdings, Inc. | 135 | 0.0% | $1,125 | 0.0% | Held | 2 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| ARK Investment Management | $2.23M | 0.0% |
Posición cerrada
| Arrowstreet Capital | $827,090 | era 0.0% |
| Citadel Advisors | $482,889 | era 0.0% |
| Mirae Asset Global… | $19,789 | era 0.0% |
| Daiwa Securities Group Inc. | $1,000 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 41 tenedores, 5.10M acciones, $528.34M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 22.83K acc. · $186,725
Director · 175 acc. · $1,446
Director · 162.76K acc. · $1.34M
Director · 14.24K acc. · $117,891
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología